The East Bay company, now down to 31 employees and a stock trading under 20 cents a share, has hired a consultant to look at financial and strategic alternatives.Migraine patch developer Zosano cuts third of jobs after FDA rejection
The East Bay company, now down to 31 employees and a stock trading under 20 cents a share, has hired a consultant to look at financial and strategic alternatives.